Advanced Medical Solutions Group Regulatory News (AMS)

16 Apr 2008 07:01

Advanced Medical Solutions Grp PLC16 April 2008 For immediate release 16 April 2008 Advanced Medical Solutions Group plc ("AMS" or "the Company") Holding in Company Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, received notification on 15 April 2008 from Mr J D Slater and family that following recent share purchases they are interested in 7,175,000 ordinary shares of 5 pence each in the Company, representing 5.013 per cent of the Company's issued share capital. For further information, please contact: Advanced Medical Solutions Group plc Don Evans, Chief Executive Officer Mary Tavener, Finance Director Tel: +44 (0) 1606 545508 www.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000 Mark Court, Mary-Jane Johnson, Stasa Filipic Landsbanki Securities (UK) Ltd Tel: +44 (0) 20 7426 9000 Shaun Dobson / Claes Spang Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $15 billion global woundcare market. Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on thedesign, development and manufacture of innovative and technologically advancedproducts for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS' resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove a product from design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing topical wounds sold direct to hospitals or throughdistributors. AMS's technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock Exchange